Navigation Links
Reliv’s LunaRich X Wins People’s Choice Stevie Award
Date:8/21/2013

Chesterfield, MO (PRWEB) August 21, 2013

Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that LunaRich X™ was named winner of the People’s Choice Stevie® Award for Favorite New Consumer Product in the 11th Annual American Business Awards.

"We know we have created a breakthrough product in LunaRich X, and this award helps confirm that,” said Dr. Carl Hastings, Reliv vice chairman and chief scientific officer. "But our greatest reward comes from hearing the remarkable health results people are achieving with the help of this cutting-edge nutritional solution.”

LunaRich X won the People’s Choice Award by polling more online votes than innovative products made by the Delta Faucet Company, Zing Anything and other companies. This is the second People’s Choice Stevie Award for Reliv. Reliv’s healthy energy shot 24K™ earned the honor in 2011.

The American Business Awards are the nation’s premier business awards program. All organizations operating in the U.S.A. are eligible to submit nominations — public and private, for-profit and non-profit, large and small. More than 3,200 nominations were submitted to this year’s American Business Awards for consideration in a wide range of categories.

What Is LunaRich X?

LunaRich X is the most pure, concentrated form of lunasin ever produced. Lunasin is a naturally occurring peptide scientists have identified as responsible for many of soy’s documented health benefits, including cholesterol support and general cellular health. Learn more about the benefits of lunasin.

Just one 125mg capsule of LunaRich X delivers the same amount of bioactive lunasin found in 25 grams of high-quality soy protein, the daily amount identified by the Food and Drug Administration to help reduce the risk of heart disease.

Lunasin is one of the first bioactive compounds identified to affect gene expression and promote optimal health at the epigenetic level. The epigenome, which literally means “beyond the genome,” is a higher level of complexity within the cell. Learn more about lunasin and nutritional epigenetics.

LunaRich X marks the culmination of an extensive research and development process that began with the discovery of the lunasin peptide by research scientist Dr. Alfredo Galvez at UC Berkley in 1996. Lunasin is now one of the most heavily researched and scientifically supported nutritional compounds available today, with more than 50 published papers from more than 25 research institutions.

About Reliv International, Inc.
Reliv International, based in Chesterfield, Mo., produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition, weight loss, athletic performance, digestive health, women's health, anti-aging and healthy energy. Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, the peptide behind many of soy’s health benefits. The company sells its products through an international network marketing system of independent distributors in 16 countries. Learn more about Reliv at http://www.reliv.com, or on Facebook, Twitter or YouTube.

About the Stevie Awards
Stevie Awards are conferred in four programs: The American Business Awards, The International Business Awards, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service. A fifth program, the Asia-Pacific Stevie Awards, will debut this year. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.StevieAwards.com/.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11045419.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Reliv’s LunaRich X Named Finalist for 2013 American Business Awards
2. Reliv’s LunaRich Earns Ingredient Patent
3. Dr. Kent Stobaugh Retiring from Oral & Maxillofacial Surgeons to Pursue Different Opportunities: SA4i Emphasizes Significant Contributions to People’s Lives
4. Voting Open for the ISE® West People’s Choice Awards
5. Healthy Lifestyle Choices Could Cut Cancer Rates: Report
6. ALS patients differ on treatment choices in later phases of disease
7. Obesity genes may influence food choices, eating patterns
8. Preteen Food Choices May Help Predict Eating Disorders Later
9. Teens Lifestyle Choices Affect Their Blood Pressure
10. Color-coded labels improve healthy food choices in employees from all backgrounds
11. Study helps pancreatic cancer patients make hard choices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
Breaking Medicine Technology: